| | Symposium on Angiogenesis, Part 1 Tumor Biology SYMPOSIUM OVERVIEW Candece L. Gladson Neuro-oncol. 2005 April; 7(2): 105. doi: 10.1215/S1152851705200133.PMCID: PMC1871886 Endogenous inhibitors of angiogenesis in malignant gliomas: Nature’s antiangiogenic therapy Tanya A. Rege, Constance Y. Fears, and Candece L. Gladson Neuro-oncol. 2005 April; 7(2): 106–121. doi: 10.1215/S115285170400119X.PMCID: PMC1871889 The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis Daniel J. Brat, Anita C. Bellail, and Erwin G. Van Meir Neuro-oncol. 2005 April; 7(2): 122–133. doi: 10.1215/ S1152851704001061.PMCID: PMC1871893 Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis Balveen Kaur, Fatima W. Khwaja, Eric A. Severson, Shannon L. Matheny, Daniel J. Brat, and Erwin G. Van Meir Neuro-oncol. 2005 April; 7(2): 134–153. doi: 10.1215/S1152851704001115.PMCID: PMC1871894 Basic and Translational Investigations Tumor Biology Functional comparison of long and short splice forms of RPTPβ: Implications for glioblastoma treatment Gustavo Lorente, April Nelson, Sabine Mueller, Jane Kuo, Roman Urfer, Karoly Nikolich, and Erik D. Foehr Neuro-oncol. 2005 April; 7(2): 154–163. doi: 10.1215/S1152851704000547.PMCID: PMC1871891 Molecular Genetics Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme Caterina Giannini, Jann N. Sarkaria, Atsushi Saito, Joon H. Uhm, Evanthia Galanis, Brett L. Carlson, Mark A. Schroeder, and C. David James Neuro-oncol. 2005 April; 7(2): 164–176. doi: 10.1215/S1152851704000821.PMCID: PMC1871885 Clinical Investigations Clinical Therapy Trials-Drug Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: A dose escalation and pharmacologic study Surasak Phuphanich, Sharyn D. Baker, Stuart A. Grossman, Kathryn A. Carson, Mark R. Gilbert, Joy D. Fisher, and Michael A. Carducci Neuro-oncol. 2005 April; 7(2): 177–182. PMCID: PMC1871887 Phase 2 study of T138067-sodium in patients with malignant glioma: Trial of the National Cancer Institute of Canada Clinical Trials Group Sarah Kirby, Stan Z. Gertler, Warren Mason, Christopher Watling, Peter Forsyth, Jacinta Aniagolu, Robert Stagg, Matthew Wright, Jean Powers, and Elizabeth A. Eisenhauer Neuro-oncol. 2005 April; 7(2): 183–188. doi: 10.1215/S1152851704000602.PMCID: PMC1871890 Clinical Therapy Trials-Outcomes Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death Jean-Blaise Wasserfallen, Sandrine Ostermann, Serge Leyvraz, and Roger Stupp Neuro-oncol. 2005 April; 7(2): 189–195. doi: 10.1215/S1152851704000687.PMCID: PMC1871888 Meeting Report Epidemiology and Cancer Control Consensus Conference on Cancer Registration of Brain and Central Nervous System Tumors Bridget J. McCarthy, Carol Kruchko, and Central Brain Tumor Registry of the United States Neuro Oncol. 2005 April; 7(2): 196–201. doi: 10.1215/S115285170400050X.PMCID: PMC1871892 Book Reviews Neuro-oncol. 2005 April; 7(2): 202–203. doi: 10.1215/S1152851704200047.PMCID: PMC1871883 Genetics: Analysis of Genes and Genomes, Sixth Edition Neuro-oncol. 2005 April; 7(2): 204–205. doi: 10.1215/S1152851704200059.PMCID: PMC1871880 MR Imaging of the Spine and Spinal Cord Neuro-oncol. 2005 April; 7(2): 206–207. doi: 10.1215/S1152851704200023.PMCID: PMC1871884 Acknowledgment to Reviewers for Neuro-Oncology Acknowledgment to Reviewers for Neuro-Oncology Darell D. Bigner Neuro-oncol. 2005 April; 7(2): 208–209. PMCID: PMC1871882 Society News and Announcements SOCIETY NEWS AND ANNOUNCEMENTS Neuro-oncol. 2005 April; 7(2): 210–211. doi: 10.1215/S1152851704200205.PMCID: PMC1871881 |